Spectrum Pharmaceutecals Inc (SPPI)

[Just Jack]

Poziotinib



Antihama - thank you for the thoughtful response earlier. I too am hoping that patient #1 is doing well, even though the odds of beating this terrible disease are extremely low. The company reported that she had immediate benefit from reduction of pain and symptoms and the most recent reports have indicated 'stable' disease progression. Based on that, I think we could see this patient still doing well. I'm hopeful that the company will give an indication on enrollment and even some early indications on tolerance, effectiveness, etc.

It's certainly time for a beneficial treatment option here.